SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material:
SEC Accession No. 0001764013-22-000068
Filing Date
2022-06-30
Accepted
2022-06-30 07:15:07
Documents
3

Document Format Files

Seq Description Document Type Size
1 DEFA14A defa14acoverpage-3x31x22.htm DEFA14A 11862
2 GRAPHIC immunovantinc_vsmvxnaxp747a.jpg GRAPHIC 489617
3 GRAPHIC immunovantinc_vsmvxnaxp747.jpg GRAPHIC 349923
  Complete submission text file 0001764013-22-000068.txt   1168880
Mailing Address 320 WEST 37TH STREET NEW YORK NY 10018
Business Address 320 WEST 37TH STREET NEW YORK NY 10018 917-580-3099
Immunovant, Inc. (Filer) CIK: 0001764013 (see all company filings)

IRS No.: 832771572 | State of Incorp.: DE | Fiscal Year End: 0331
Type: DEFA14A | Act: 34 | File No.: 001-38906 | Film No.: 221056493
SIC: 2836 Biological Products, (No Diagnostic Substances)
Office of Life Sciences